This inventor holds 1 USPTO granted patent. Top assignees: Glaxo Group Limited, Smithkline Beecham Corporation. Active years: 2007.
Company Filing History:
1 out of 1,169 
1 out of 2,198 Years Active: 2007
Title: Richard Stephen Hale: Innovator in Nogo Function Modulation
Introduction
Richard Stephen Hale is a notable inventor based in Stevenage, GB. He has made significant contributions to the field of biotechnology, particularly in the area of Nogo functions. His innovative approach has led to the development of a unique method that has potential implications in various therapeutic applications.
Latest Patents
Richard Stephen Hale holds a patent for a "Method of identifying modulators of Nogo-functions." This method involves identifying a modulator of Nogo function, which could play a crucial role in understanding and potentially treating conditions related to nerve regeneration and repair. He has 1 patent to his name, showcasing his inventive capabilities.
Career Highlights
Throughout his career, Hale has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Glaxo Group Limited and SmithKline Beecham Corporation. His experience in these organizations has provided him with a solid foundation in research and development, allowing him to contribute effectively to the field.
Collaborations
Richard has collaborated with esteemed colleagues, including Walter Philip Blackstock and Rabinder Kumar Prinjha. These partnerships have likely enriched his research and innovation efforts, fostering a collaborative environment that encourages the exchange of ideas and expertise.
Conclusion
In summary, Richard Stephen Hale is a distinguished inventor whose work in identifying modulators of Nogo functions has the potential to impact the field of biotechnology significantly. His career, marked by collaborations and contributions to major pharmaceutical companies, highlights his dedication to advancing scientific knowledge and innovation.